Holen Sie sich die Stockscreener-App
31.77
0.72%
-0.23
Schlusskurs vom Vortag:
$32.00
Offen:
$32.03
24-Stunden-Volumen:
253.53K
Relative Volume:
0.82
Marktkapitalisierung:
$1.02B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
26.70
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
-1.82%
1M Leistung:
+6.93%
6M Leistung:
-5.05%
1J Leistung:
-0.56%
1-Tages-Spanne:
$31.62
$32.32
1-Wochen-Bereich:
$31.62
$33.22
52-Wochen-Spanne:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
31.77 | 1.04B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
151.54 | 70.46B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.78B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.69 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.01 | 19.16B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.16 | 13.56B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
What makes Collegium Pharmaceutical Inc. stock price move sharplyMassive Gain Ideas - Newser
Why Collegium Pharmaceutical Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityTargeted 200 Percent Gain - Newser
(COLL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLC - Defense World
Collegium Pharmaceutical (COLL) Soars 1.98% on Strong Q1 Earnings - AInvest
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st
Collegium announces $150M share repurchase program - MSN
Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical authorizes $150 million share repurchase program By Investing.com - Investing.com Nigeria
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market - Nasdaq
Collegium Pharmaceutical authorizes $150 million share repurchase program - Investing.com
Collegium Announces $150 Million Share Repurchase Program - GlobeNewswire
COLL announces $150M share buyback through 2026 – cash-funded | COLL SEC FilingForm 8-K - Stock Titan
Collegium Expands Shareholder Returns With Fresh $150M Stock Buyback After Returning $222M Since 2021 - Stock Titan
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Buy” at Wall Street Zen - Defense World
How To Trade (COLL) - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Lowered by Illinois Municipal Retirement Fund - Defense World
Janney Montgomery Scott LLC Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
State of Alaska Department of Revenue Decreases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
SG Americas Securities LLC Has $426,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Director’s Bold Move: Major Stock Sale at Collegium Pharmaceutical - TipRanks
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers - Yahoo Finance
Bank of America Corp DE Reduces Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Two Sigma Investments LP Sells 135,582 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
ProShare Advisors LLC Increases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Millennium Management LLC Raises Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ameriprise Financial Inc. - Defense World
Deutsche Bank AG Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Jane Street Group LLC Sells 20,543 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.80 - Defense World
Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Collegium Pharmaceutical Approves 2025 Equity Incentive Plan - TipRanks
Collegium Pharmaceutical, Inc. to Present at Mizuho Neuro & Ophthalmology Summit and Jefferies Global Healthcare Conference - Nasdaq
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical to Present at Mizuho Neuro Summit and Jefferies Healthcare Conference - Stock Titan
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Comerica Bank - Defense World
There May Be Reason For Hope In Collegium Pharmaceutical's (NASDAQ:COLL) Disappointing Earnings - simplywall.st
Voya Investment Management LLC Sells 789 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Initiates $25 Million Share Repu - GuruFocus
Collegium Pharmaceutical buys back $25 million in shares By Investing.com - Investing.com Canada
Collegium Pharmaceutical initiates $25M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies - marketscreener.com
Collegium Announces $25 Million Accelerated Share Repurchase Program - marketscreener.com
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.43%
1.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):